Blood pressure (BP) control for renal protection is essential for patients with type 2 diabetes. Our objective in this analysis of Veterans Affairs Diabetes Trial (VADT) data was to learn whether on-study systolic BP (SBP), diastolic BP (DBP), and pulse pressure (PP) affected renal outcomes measured as albumin-to-creatinine ratio (ACR) and estimated glomerular filtration rate (eGFR). RESEARCH DESIGN AND METHODS The VADT was a prospective, randomized study of 1,791 veterans with type 2 diabetes to determine whether intensive glucose control preventedmajor cardio-vascular events. In this post hoc study, time-varying covariate survival analyses and hazard ratios (HR) were used to determine worsening of renal outcomes. RESULTS Compared with SBP...
Intensive BP control and/or glucose control did not reduce microvascular events in hypertensive type...
BackgroundThe ideal blood pressure (BP) to decrease mortality rates in patients with non-dialysis-de...
The optimal blood pressure (BP) goal in patients with diabetes mellitus remains controversial. We ex...
Blood pressure (BP) control for renal protection is essential for patients with type 2 diabetes. Our...
OBJECTIVE—The Veterans Affairs Diabetes Trial (VADT) was a randomized, prospective, controlled trial...
ObjectiveTo compare different blood pressure (BP) levels in their association with the risk of renal...
ObjectiveIn patients with type 2 diabetes and diabetic kidney disease (DKD), explore the relationshi...
ObjectiveIn patients with type 2 diabetes and diabetic kidney disease (DKD), explore the relationshi...
Contains fulltext : 79936_pub.pdf (publisher's version ) (Closed access) ...
BACKGROUND:The Systolic Blood Pressure Intervention Trial (SPRINT; ClinicalTrials.gov, NCT01206062) ...
Elevated arterial pressure is a major risk factor for progression to ESRD in diabetic nephropathy. H...
Elevated arterial pressure is a major risk factor for progression to ESRD in diabetic nephropathy. H...
The relative importance of various blood pressure indices on cardiovascular risk in people with type...
Pulse pressure (PP) remains an elusive cardiovascular risk factor with inconsistent findings. We cla...
Pulse pressure ( PP ) remains an elusive cardiovascular risk factor with inconsistent findings. We c...
Intensive BP control and/or glucose control did not reduce microvascular events in hypertensive type...
BackgroundThe ideal blood pressure (BP) to decrease mortality rates in patients with non-dialysis-de...
The optimal blood pressure (BP) goal in patients with diabetes mellitus remains controversial. We ex...
Blood pressure (BP) control for renal protection is essential for patients with type 2 diabetes. Our...
OBJECTIVE—The Veterans Affairs Diabetes Trial (VADT) was a randomized, prospective, controlled trial...
ObjectiveTo compare different blood pressure (BP) levels in their association with the risk of renal...
ObjectiveIn patients with type 2 diabetes and diabetic kidney disease (DKD), explore the relationshi...
ObjectiveIn patients with type 2 diabetes and diabetic kidney disease (DKD), explore the relationshi...
Contains fulltext : 79936_pub.pdf (publisher's version ) (Closed access) ...
BACKGROUND:The Systolic Blood Pressure Intervention Trial (SPRINT; ClinicalTrials.gov, NCT01206062) ...
Elevated arterial pressure is a major risk factor for progression to ESRD in diabetic nephropathy. H...
Elevated arterial pressure is a major risk factor for progression to ESRD in diabetic nephropathy. H...
The relative importance of various blood pressure indices on cardiovascular risk in people with type...
Pulse pressure (PP) remains an elusive cardiovascular risk factor with inconsistent findings. We cla...
Pulse pressure ( PP ) remains an elusive cardiovascular risk factor with inconsistent findings. We c...
Intensive BP control and/or glucose control did not reduce microvascular events in hypertensive type...
BackgroundThe ideal blood pressure (BP) to decrease mortality rates in patients with non-dialysis-de...
The optimal blood pressure (BP) goal in patients with diabetes mellitus remains controversial. We ex...